{'52WeekChange': 0.045636535,
 'SandP52WeekChange': 0.0644362,
 'address1': 'Am Strande 7',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 13.23,
 'askSize': 3000,
 'averageDailyVolume10Day': 502350,
 'averageVolume': 146728,
 'averageVolume10days': 502350,
 'beta': None,
 'beta3Year': None,
 'bid': 12.97,
 'bidSize': 1000,
 'bookValue': None,
 'category': None,
 'circulatingSupply': None,
 'city': 'Rostock',
 'companyOfficers': [],
 'country': 'Germany',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 13.9,
 'dayLow': 12.45,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': 264354432,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '49 381 8011 3401',
 'fiftyDayAverage': 17.919144,
 'fiftyTwoWeekHigh': 28.711,
 'fiftyTwoWeekLow': 7.8,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 6188794,
 'forwardEps': -0.99,
 'forwardPE': -13.191919,
 'fromCurrency': None,
 'fullTimeEmployees': 440,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.28452998,
 'heldPercentInstitutions': 0.23672001,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/centogene.com',
 'longBusinessSummary': 'Centogene N.V. operates as a commercial-stage rare '
                        'disease company in Europe, Middle East, North '
                        'America, Latin America, and Asia Pacific. The company '
                        'operates through two segments, Pharmaceutical and '
                        'Diagnostics. The Pharmaceutical segment offers '
                        'various services, including early patient recruitment '
                        'and identification, epidemiological insights, '
                        'biomarker discovery, and patient monitoring. The '
                        'Diagnostics segment provides genetic sequencing and '
                        'diagnostics services to physicians, laboratories, or '
                        'hospitals directly or through distributors. It '
                        'focuses on transforming clinical and genetic data '
                        'into medical solutions for patients, physicians, and '
                        'pharmaceutical companies. The company develops rare '
                        'disease platform based on data repository, which '
                        'includes epidemiologic, phenotypic, proteomic, and '
                        'genetic data that enhances methods for identifying '
                        'and monitoring rare hereditary diseases and provide '
                        'solutions that accelerate the development of orphan '
                        'drugs. Centogene N.V. was founded in 2006 and is '
                        'headquartered in Rostock, Germany.',
 'longName': 'Centogene N.V.',
 'market': 'us_market',
 'marketCap': 259388592,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_606770426',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': None,
 'nextFiscalYearEnd': 1640908800,
 'open': 13.8,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '49 381 8011 3500',
 'previousClose': 13.31,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': -0.48455003,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 13.9,
 'regularMarketDayLow': 12.45,
 'regularMarketOpen': 13.8,
 'regularMarketPreviousClose': 13.31,
 'regularMarketPrice': 13.8,
 'regularMarketVolume': 657423,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 19861300,
 'sharesPercentSharesOut': 0.0047999998,
 'sharesShort': 94467,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 29255,
 'shortName': 'Centogene N.V.',
 'shortPercentOfFloat': 0.0233,
 'shortRatio': 2.35,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'CNTG',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 16.383202,
 'volume': 657423,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.centogene.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '18055'}